Breast Cancer Index Test: Helping to Reduce the Uncertainty of Breast Cancer Treatment
Disclosure: This post is sponsored by Biotheranostics, Inc. (Breast Cancer Index®). Thoughts and opinions are 100% my own.
I think it’s probably safe to say that we’ve all been impacted or affected by cancer in one way or another. My hope for you is that you have not, but the odds are that someone you know and love has struggled through the frightening paths of cancer. Maybe you’ve even struggled with cancer yourself.
While we all have different stories and experiences, the one thing that we know to be true is that cancer is a beast. A heartbreaking and scary time for those facing it and a very uncertain and helpless time for family and friends.
I try to be very intentional with the things that I share here on the blog with you. I do my research and my hope is that I’m bringing you value in whatever I share – be it a recipe or a great online deal – or in this case, what I truly feel to be beneficial and possibly life saving information that until recently, I had no idea existed.
Why I am taking on this particular partnership with the maker of Breast Cancer Index? Because like so many of you my life has been touched by this horrible disease and what it has done to those that I love and care about.
One of my best friends lost her husband to cancer a couple of years ago, my cousin lost his sweet wife Katie to breast cancer (if you’ve been a long time reader of She Saved, you might remember the Team Katie posts from ten years ago) and most recently, one of my very dear friends was diagnosed with breast cancer and I’ve watched as this past year has been a literal roller coaster of emotions, challenges and changes.
So, while I can’t cure cancer and I can’t make it go away – I can research and share information, so I’m committed to learning more about this option for women and why knowledge is power when it comes to our health.
What is Breast Cancer Index?
When a woman is first diagnosed with breast cancer, a wave of everything from emotions to medical treatments, options and courses of action come flooding into her life. Overwhelming to say the least.
Breast Cancer Index is the only commercially available genomic test that can 1) predict whether a breast cancer patient is likely to benefit from antiestrogen therapy after 5 years and 2) provide the patient’s individual risk of recurrence after 5 years. Learn more here.
Why is this important? Because until now, oncologists have had limited tools to determine whether a patient is likely to benefit from anti-estrogen treatment after five years.
This is significant because nearly 95% of women with HR+, early-stage breast cancer do not benefit from anti-estrogen therapy beyond 5 years. Furthermore, anti-estrogen therapy has significant negative side-effects that can cause life-long problems.
Breast Cancer Index predicts whether she is among those likely to benefit from continuing treatment, to help her and her healthcare team determine what is right for her.
What This Test Does
A breast cancer diagnosis means that a woman is instantly thrown into a world of uncertainty. So many questions, options and information to absorb for this new normal. In the words of Breast Cancer Index, here is what it does to help alleviate some of the uncertainty for breast cancer patients:
Breast Cancer Index is shifting the paradigm when it comes to breast cancer treatment.
While some women do, nearly 95% of women with HR+, early-stage breast cancer do not benefit from endocrine therapy after five years.
100% of women deserve to know what is right for them. Just as Oncotype is the gold standard for determining likelihood of benefit from chemotherapy, Breast Cancer Index is the only commercially available, genomic test that determines whether patients are likely to benefit from anti-estrogen therapy after year five.
By reducing the fear and uncertainty surrounding treatment decisions for patients and their providers, Breast Cancer Index is an important test for extended anti-estrogen therapy decision-making.
We believe women and their oncologists shouldn’t spend another minute not knowing whether longer treatment is likely to benefit them.
Why Breast Cancer Index
Because knowledge is power and a breast cancer diagnosis comes with a lot of uncertainty and fear.
Breast Cancer Index is driven by data and guided by experience.
Breast Cancer Index and the people behind the brand are committed to serving as an ally to the provider-patient team by supporting physicians in their oath to do no harm, and reducing uncertainty for patients.
Not another Minute of Uncertainty
A patient and her physician shouldn’t spend one more minute unsure about whether she is likely to benefit from extended anti-estrogen therapy.
As mentioned earlier, while some women do, nearly 95% of women with hormone receptor positive (HR+), early-stage breast cancer do not benefit from anti-estrogen therapy after five years.
100% of women deserve to know what is right for them. Breast Cancer Index is here to help.
Convicted in their mission that not another minute is wasted, not another patient goes without knowing and not another day goes by without being on the right treatment path, the maker of Breast Cancer Index understands that while they can’t take the fear out of cancer, they can reduce the uncertainty around treating it.
How to get a Breast Cancer Index Test
Please ask your doctor if the Breast Cancer Index test is right for you and find more information on the Breast Cancer Index website.
The creative and frugal mind behind She Saved for almost 12 years now, Keri Lyn shares her adventures in parenting along with her love for family travel, country living and brand marketing. A self-proclaimed “brand loyalist”, Keri Lyn is known for her strong and enthusiastic voice when it comes to the products and brands that she loves. Passionate about family and the challenge of raising good humans (through the teen years, no less!) Keri Lyn has also served as a brand ambassador to many brands including her time as a Hilton Mom Voyage travel writer and currently an O Mag Insider for O, The Oprah Magazine and the 2019 recipient the O-verall Contribution O-ward.
Lois Christensen says
Keri Lyn says